Drugs Made In America Acquisition II Corp. (DMII) Institutional Ownership

Ownership Summary

Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) showed up in the 13F filings of 51 institutional investors as of December 2025.

• Their total shares held in DMII increased 0.0% quarter over quarter, and separately, investors owning Drugs Made In America Acquisition stayed flat from a year ago.
• During the quarter, 51 of these 51 funds increased positions in DMII, 0 reduced exposure, and 0 held steady.
• In total, institutional investors held 35.06Mn shares in Drugs Made In America Acquisition as of December 2025, up by 35.06Mn shares quarter on quarter, and with no net change year over year.
• As of December 31, 2025, Magnetar Financial LLC held the largest stake in Drugs Made In America Acquisition with 2.7Mn shares, accounting for 17.67% of total shares outstanding.
• The biggest buyers of Drugs Made In America Acquisition for the quarter ending December 2025 included MMCAP International Inc. SPC (2.7Mn), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (2.0Mn), Karpus Management, Inc. (1.45Mn), Mercuria Capital Strategies, LLC (750.0K), WOLVERINE ASSET MANAGEMENT LLC (732.52K).
• The biggest sellers of Drugs Made In America Acquisition for the quarter ending December 2025 included First Trust Capital Management L.P. (1.0Mn), CSS LLC/IL (695.96K), Lineage Point Capital LP (336.36K), MIZUHO SECURITIES USA LLC (197.71K), Clear Street Group Inc. (166.18K).
• Per Business Quant data, the top 10 holders of Drugs Made In America Acquisition for the quarter ending December 2025 are Magnetar Financial LLC (2.7Mn), MMCAP International Inc. SPC (2.7Mn), Karpus Management, Inc. (2.6Mn), GLAZER CAPITAL, LLC (2.35Mn), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (2.0Mn), MILLENNIUM MANAGEMENT LLC (1.98Mn), Hudson Bay Capital Management LP (1.97Mn), WOLVERINE ASSET MANAGEMENT LLC (1.8Mn), Polar Asset Management Partners Inc. (1.5Mn), TENOR CAPITAL MANAGEMENT Co., L.P. (1.5Mn).